摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-5,8-二酮 | 119584-65-5

中文名称
1,4,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-5,8-二酮
中文别名
——
英文名称
4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione
英文别名
1,4,6,7-tetrahydroimidazo[4,5-e][1,4]diazepine-5,8-dione
1,4,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-5,8-二酮化学式
CAS
119584-65-5
化学式
C6H6N4O2
mdl
MFCD01208156
分子量
166.139
InChiKey
FXQGXBGGCANVFZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >340 °C
  • 沸点:
    865.6±60.0 °C(Predicted)
  • 密度:
    1.502±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    86.9
  • 氢给体数:
    3
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2933990090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    —— 1-benzyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 119584-61-1 C13H12N4O2 256.264
    —— 5(4)-amino-4(5)-(N-carboxymethyl)carbamoyl-1(3)H-imidazole 132459-08-6 C6H8N4O3 184.155
    —— 5(4)-amino-4(5)-(N-methoxycarbonylmethyl)carbamoyl-1(3)H-imidazole 132459-07-5 C7H10N4O3 198.181
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    —— 1-methyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 109541-04-0 C7H8N4O2 180.166
    —— 1,4-Dimethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>-diazepine-5,8-dione 130063-15-9 C8H10N4O2 194.193
    —— 1,4,7-trimethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 76170-95-1 C9H12N4O2 208.22

反应信息

点击查看最新优质反应信息

文献信息

  • Cyclic homologs of xanthines.<b>I</b>. Imidazo[4,5-<i>e</i>][1,4]diazepine-5,8-diones
    作者:Peter K. Bridson、Timothy P. Weirich
    DOI:10.1002/jhet.5570250426
    日期:1988.7
    A useful synthetic approach to variously alkylated 4,5,7,8-tetrahydro-6.H-imidazo[4,5-e][1,4]diazepine-5,8-diones is reported. These compounds are potentially interesting cyclic homologs of pharmacologically important alkylxanthines.
    一种有用的合成方法,用于各种烷基化的4,5,7,8-四氢-6。报道了H-咪唑并[4,5- e ] [1,4]二氮杂-5,8-二酮。这些化合物可能是药理上重要的烷基黄嘌呤的有趣的环状同系物。
  • Ring expanded nucleosides and nucleotides
    申请人:——
    公开号:US20040077564A1
    公开(公告)日:2004-04-22
    The present invention relates to compositions comprising analogues of purine nucleosides containing a ring-expanded (“fat”) heterocyclic ring, in place of purine, and an unmodified or modified sugar residue, pharmaceutically acceptable derivatives of such compositions, as well as methods of use thereof. In particular, these compositions may be utilized in the treatment of certain cancers, bacterial, fungal, parasitic, and viral infections, including, but not limited to, Acquired Immunodeficiency Syndrome (AIDS), hepatitis, Epstein-Barr and cytomegalovirus.
    本发明涉及含有环扩张(“肥胖”)杂环环代替嘌呤的嘌呤核苷类似物和未经改性或改性的糖残基的组合物,以及这些组合物的药学上可接受的衍生物,以及其使用方法。特别地,这些组合物可用于治疗某些癌症、细菌、真菌、寄生虫和病毒感染,包括但不限于获得性免疫缺陷综合症(AIDS)、肝炎、EB病毒和巨细胞病毒。
  • Ring-expanded nucleosides and nucleotides
    申请人:Nabi
    公开号:EP1227103B1
    公开(公告)日:2006-07-26
  • Hosmane, Ramachandra S.; Bhan, Anila, Journal of Heterocyclic Chemistry, 1990, vol. 27, # 7, p. 2189 - 2196
    作者:Hosmane, Ramachandra S.、Bhan, Anila
    DOI:——
    日期:——
  • IVANOV, EH. I.;KALAYANOV, G. D.;YAROSHENKO, I. M., XIMIYA GETEROTSIKL. SOED.,(1990) N, S. 997-998
    作者:IVANOV, EH. I.、KALAYANOV, G. D.、YAROSHENKO, I. M.
    DOI:——
    日期:——
查看更多

同类化合物

脱氧助间型霉素 化合物RK-33 8-叔-丁基1-乙基6,7-二氢-5H-咪唑并[1,5-A][1,4]二氮杂卓-1,8(9H)-二甲酸基酯 8-(叔丁氧羰基)-6,7,8,9-四氢-5H-咪唑并[1,5-A][1,4]二氮杂-1-羧酸 6-羟基-4,5,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-8(1H)-酮 5-(8-羟基-7,8-二氢-4H-咪唑并[5,4-d][1,3]二氮杂卓-3-基)-3-(羟基甲基)环戊-3-烯-1,2-二醇 4,7-二氢咪唑并[4,5-d][1,3]二氮杂卓-8(1H)-酮 3-[(2-羟基乙氧基)甲基]-3,4,7,8-四氢咪唑并[4,5-d][1,3]二氮杂卓-8-醇 1H-咪唑并[1,5-d〕〔1,4]二氮杂(9CI) 1,4,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-5,8-二酮 (9ci)-1H-咪唑并[1,2-a][1,4]二氮杂卓 5-methylthio-11H-imidazo[1,2-c][1,3]benzodiazepine 2-methoxy-1,4,7-trimethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-5,7-diphenyl-4,5,7,8-tetrahydroimidazo<4,5-e><1,3>diazepin-6-one 6-amino-4,5-dihydro-8H-imidazo[4,5-e][1,3]diazepine-4,8-dione [3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8 tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol]-5'-phosphoric Acid-(3-dodecylmercapto-2-decyloxy)-propyl Ester (4S)-4-benzyl-2-(2,5-dihydroxyphenyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo-[4,5-d][1,3]diazepin-5-one (4S)-4-benzyl-2-(2,5-dimethoxyphenyl)-3,4-dihydro-5H-pyrido[10,20:1,2]imidazo [4,5-d][1,3]diazepin-5-one (4S)-4-methyl-2-(1-naphthyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo-[4,5-d][1,3]diazepin-5-one 6-amino-1-(2'-deoxy-β-D-erythropentofuranosyl)-4,5-dihydro-8H-imidazo[4,5-e][1,3]diazepine-4,8-dione 6-amino-1-(2'-deoxy-α-D-erythropentofuranosyl)-4,5-dihydro-8H-imidazo[4,5-e][1,3]diazepine-4,8-dione (4S)-4-methyl-2-(4-acetamidophenyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo-[4,5-d][1,3]diazepin-5-one 5-(4-methyl-1-piperazinyl)-11H-imidazo[1,2-c][1,3]benzodiazepine monomaleate (8R)-3-[(4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol (R)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol 6-(decylamino)-1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-imidazo[4,5-e][1,3]diazepine-4,8-dione (13S)-11-(4-methoxyphenyl)-13-methyl-2,8,10,12-tetrazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7,11-pentaen-14-one (8R)-3-[(2S,4S,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol 8-Ketodeoxycoformycin 2'-chloropentostatin CO-Vidarabine (8R)-3-[(1S,2R,4R)-2-(benzoyloxymethyl)-1-benzoyloxycyclopent-4-yl]-8-[(tert-butyldimethylsilyl)oxy]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepine (8R)-3-Benzyl-6-(tert-butoxycarbonyl)-8-<(tert-butyldimethylsilyl)oxy>-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepine (8R)-3-(2'-Cyanoethyl)-8-<(tert-butyldimethylsilyl)oxy>-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepine 4-propyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-4-propyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 4-isobutyl-7-methyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-4,7-diethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-4-isobutyl-7-methyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 4,6-diamino-6-(ethylimino)-1,6-dihydroimidazo[4,5-e][1,3]diazepine 4,5-dihydro-8H-6-(N-hexadecyl)amino-1-(2'-deoxy-α-D-erythropentofuranosyl)imidazo[4,5-e]diazepine-4,8-dione 4,5-dihydro-8H-6-(N-tetradecyl)amino-1-(2'-deoxy-α-D-erythropentofuranosyl)imidazo[4,5-e]diazepine-4,8-dione 4,5-dihydro-8H-6-(N-octadecyl)amino-1-(2-deoxy-α-D-erythropentofuranosyl)imidazo[4,5-e]diazepine-4,8-dione 4,6-diamino-6-(octadecylimino)-1,6-dihydroimidazo[4,5-e][1,3]diazepine 8-Imino-2,4-dimethyl-7-phenyl-7,8-dihydro-4H-1,2a,4,5,7-pentaaza-cyclopenta[cd]azulene-3,6-dione 1,4-dimethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 11H-imidazo[1,2-c][1,3]benzodiazepine-5(6H)-thione (8R)-3-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol 2-(4-Chloro-benzylcarbamoyl)-6-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-hexanoic acid benzyl ester (13S)-13-(1H-indol-3-ylmethyl)-2,8,10,12-tetrazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7-tetraene-11,14-dione